Key Findings:  This study found that four of the five minor cannabinoids [cannabinol (CBN), cannabidivarin (CBDV), cannabigerol (CBG), Δ8-tetrahydrocannabinol (Δ8-THC), and Δ9-tetrahydrocannabivarin (THCV)] showed cannabimimetic activity, while one was efficacious in relieving chronic neuropathic pain. Only CBN effectively relieved chemotherapy-induced peripheral neuropathy (CIPN) pain.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2024
Cannabinoids Studied:  Cannabigerol (CBG), Cannabinol (CBN), Tetrahydrocannabivarin (THCV), Delta-8-THC, Cannabidivarin (CBDV)
Phytocannabinoid Source:  Not Applicable
Citation:  Schwarz AM, et al. Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain. J Pharmacol Exp Ther. 2024; 391:214-221. doi: 10.1124/jpet.124.002212
Authors:  Schwarz AM, Kobeci D, Mancuso JA, Moreno-Rodríguez V, Seekins C, Bui T, Welborn A, Carr J, Streicher JM